Skip to main content
Top
Published in: Virchows Archiv 4/2017

01-04-2017 | Original Article

Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue

Authors: Samatha Bhat, Shama Prasada Kabekkodu, Chinchu Jayaprakash, Raghu Radhakrishnan, Satadru Ray, Kapaettu Satyamoorthy

Published in: Virchows Archiv | Issue 4/2017

Login to get access

Abstract

The present study was undertaken to explore and validate novel hypermethylated DNA regions in squamous cell carcinoma of the tongue (SCCT). Genome-wide methylation changes were identified by differential methylation hybridization (DMH) microarray and validated by bisulfite genome sequencing (BGS). The results were compared against datasets from The Cancer Genome Atlas head and neck squamous cell carcinoma (TCGA-HNSCC), Gene Expression Omnibus (GSE26549), and ArrayExpress (E-MTAB-1328). DMH identified 116 hypomethylated and 241 hypermethylated regions. Of the latter, 24 were localized to promoter or 5′-UTR regions. By BGS, promoter sequences of DAPK1, LRPPRC, RAB6C, and ZNF471 were significantly hypermethylated in tumors when compared with matched normal tissues (P < 0.0001). A TCGA-HNSCC dataset (516 cases of cancer and 50 normal tissue samples) further confirmed hypermethylation of DAPK1, RAB6C, and ZNF471. Sensitivity and specificity of methylation markers for a diagnosis of cancer were in the range of 70–100% in our study and from TCGA-HNSCC datasets, with an area under curve (AUC) of 0.83 and above. Kaplan-Meier survival analysis of TCGA-HNSCC expression data revealed that patients with low expressions of DAPK1, RAB6C, and ZNF471 showed poorer survival than patients with high expression (P = 0.02). Human papillomavirus (HPV) was found in 55% of cases, HPV16 being the predominant genotype. DAPK1 immunohistochemical staining was lower in SCCT than in normal buccal epithelial cells. This is the first study to report hypermethylation of LRPPRC, RAB6C, and ZNF471 in SCCT and its diagnostic and prognostic potentials in a specific head and neck squamous cell carcinoma.
Appendix
Available only for authorised users
Literature
1.
go back to reference Daley T, Darling M (2003) Nonsquamous cell malignant tumours of the oral cavity: an overview. J Can Dent Assoc 69(9):577–582PubMed Daley T, Darling M (2003) Nonsquamous cell malignant tumours of the oral cavity: an overview. J Can Dent Assoc 69(9):577–582PubMed
2.
go back to reference Parkin DM, Pisani P, Ferlay J (1999) Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80(6):827–841CrossRefPubMed Parkin DM, Pisani P, Ferlay J (1999) Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80(6):827–841CrossRefPubMed
4.
go back to reference Mishra A, Meherotra R (2014) Head and neck cancer: global burden and regional trends in India. Asian Pacific Journal of Cancer Prevention : APJCP 15(2):537–550CrossRefPubMed Mishra A, Meherotra R (2014) Head and neck cancer: global burden and regional trends in India. Asian Pacific Journal of Cancer Prevention : APJCP 15(2):537–550CrossRefPubMed
5.
go back to reference Kuriakose M, Sankaranarayanan M, Nair MK, Cherian T, Sugar AW, Scully C, Prime SS (1992) Comparison of oral squamous cell carcinoma in younger and older patients in India. Eur J Cancer B Oral Oncol 28B(2):113–120CrossRefPubMed Kuriakose M, Sankaranarayanan M, Nair MK, Cherian T, Sugar AW, Scully C, Prime SS (1992) Comparison of oral squamous cell carcinoma in younger and older patients in India. Eur J Cancer B Oral Oncol 28B(2):113–120CrossRefPubMed
6.
go back to reference Llewellyn CD, Johnson NW, Warnakulasuriya KA (2001) Risk factors for squamous cell carcinoma of the oral cavity in young people—a comprehensive literature review. Oral Oncol 37(5):401–418CrossRefPubMed Llewellyn CD, Johnson NW, Warnakulasuriya KA (2001) Risk factors for squamous cell carcinoma of the oral cavity in young people—a comprehensive literature review. Oral Oncol 37(5):401–418CrossRefPubMed
9.
go back to reference Krishnan NM, Dhas K, Nair J, Palve V, Bagwan J, Siddappa G, Suresh A, Kekatpure VD, Kuriakose MA, Panda B (2016) A minimal DNA methylation signature in oral tongue squamous cell carcinoma links altered methylation with tumor attributes. Mol Cancer Res. doi:10.1158/1541-7786.MCR-15-0395 PubMed Krishnan NM, Dhas K, Nair J, Palve V, Bagwan J, Siddappa G, Suresh A, Kekatpure VD, Kuriakose MA, Panda B (2016) A minimal DNA methylation signature in oral tongue squamous cell carcinoma links altered methylation with tumor attributes. Mol Cancer Res. doi:10.​1158/​1541-7786.​MCR-15-0395 PubMed
10.
go back to reference Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, Fakhry C, Xie TX, Zhang J, Wang J, Zhang N, El-Naggar AK, Jasser SA, Weinstein JN, Trevino L, Drummond JA, Muzny DM, Wu Y, Wood LD, Hruban RH, Westra WH, Koch WM, Califano JA, Gibbs RA, Sidransky D, Vogelstein B, Velculescu VE, Papadopoulos N, Wheeler DA, Kinzler KW, Myers JN (2011) Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333(6046):1154–1157. doi:10.1126/science.1206923 CrossRefPubMedPubMedCentral Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, Fakhry C, Xie TX, Zhang J, Wang J, Zhang N, El-Naggar AK, Jasser SA, Weinstein JN, Trevino L, Drummond JA, Muzny DM, Wu Y, Wood LD, Hruban RH, Westra WH, Koch WM, Califano JA, Gibbs RA, Sidransky D, Vogelstein B, Velculescu VE, Papadopoulos N, Wheeler DA, Kinzler KW, Myers JN (2011) Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333(6046):1154–1157. doi:10.​1126/​science.​1206923 CrossRefPubMedPubMedCentral
12.
go back to reference Hu Z, Zhong Z, Huang S, Wen H, Chen X, Chu H, Li Q, Sun C (2016) Decreased expression of Beclin1 is significantly associated with a poor prognosis in oral tongue squamous cell carcinoma. Mol Med Rep. doi:10.3892/mmr.2016.5437 Hu Z, Zhong Z, Huang S, Wen H, Chen X, Chu H, Li Q, Sun C (2016) Decreased expression of Beclin1 is significantly associated with a poor prognosis in oral tongue squamous cell carcinoma. Mol Med Rep. doi:10.​3892/​mmr.​2016.​5437
15.
go back to reference Chen HC, Yang CM, Cheng JT, Tsai KW, Fu TY, Liou HH, Tseng HH, Lee JH, Li GC, Wang JS, Hou YY, Weng TJ, Ger LP (2016) Global DNA hypomethylation is associated with the development and poor prognosis of tongue squamous cell carcinoma. J Oral Pathol Med 45(6):409–417. doi:10.1111/jop.12381 CrossRefPubMed Chen HC, Yang CM, Cheng JT, Tsai KW, Fu TY, Liou HH, Tseng HH, Lee JH, Li GC, Wang JS, Hou YY, Weng TJ, Ger LP (2016) Global DNA hypomethylation is associated with the development and poor prognosis of tongue squamous cell carcinoma. J Oral Pathol Med 45(6):409–417. doi:10.​1111/​jop.​12381 CrossRefPubMed
16.
go back to reference Nagata S, Hamada T, Yamada N, Yokoyama S, Kitamoto S, Kanmura Y, Nomura M, Kamikawa Y, Yonezawa S, Sugihara K (2012) Aberrant DNA methylation of tumor-related genes in oral rinse: a noninvasive method for detection of oral squamous cell carcinoma. Cancer 118(17):4298–4308. doi:10.1002/cncr.27417 CrossRefPubMed Nagata S, Hamada T, Yamada N, Yokoyama S, Kitamoto S, Kanmura Y, Nomura M, Kamikawa Y, Yonezawa S, Sugihara K (2012) Aberrant DNA methylation of tumor-related genes in oral rinse: a noninvasive method for detection of oral squamous cell carcinoma. Cancer 118(17):4298–4308. doi:10.​1002/​cncr.​27417 CrossRefPubMed
17.
go back to reference Ovchinnikov DA, Cooper MA, Pandit P, Coman WB, Cooper-White JJ, Keith P, Wolvetang EJ, Slowey PD, Punyadeera C (2012) Tumor-suppressor gene promoter hypermethylation in saliva of head and neck cancer patients. Transl Oncol 5(5):321–326CrossRefPubMedPubMedCentral Ovchinnikov DA, Cooper MA, Pandit P, Coman WB, Cooper-White JJ, Keith P, Wolvetang EJ, Slowey PD, Punyadeera C (2012) Tumor-suppressor gene promoter hypermethylation in saliva of head and neck cancer patients. Transl Oncol 5(5):321–326CrossRefPubMedPubMedCentral
18.
go back to reference Rettori MM, de Carvalho AC, Bomfim Longo AL, de Oliveira CZ, Kowalski LP, Carvalho AL, Vettore AL (2013) Prognostic significance of TIMP3 hypermethylation in post-treatment salivary rinse from head and neck squamous cell carcinoma patients. Carcinogenesis 34(1):20–27. doi:10.1093/carcin/bgs311 CrossRefPubMed Rettori MM, de Carvalho AC, Bomfim Longo AL, de Oliveira CZ, Kowalski LP, Carvalho AL, Vettore AL (2013) Prognostic significance of TIMP3 hypermethylation in post-treatment salivary rinse from head and neck squamous cell carcinoma patients. Carcinogenesis 34(1):20–27. doi:10.​1093/​carcin/​bgs311 CrossRefPubMed
19.
go back to reference Zhang S, Feng XL, Shi L, Gong CJ, He ZJ, Wu HJ, Ling TY (2013) Genome-wide analysis of DNA methylation in tongue squamous cell carcinoma. Oncol Rep 29(5):1819–1826. doi:10.3892/or.2013.2309 PubMed Zhang S, Feng XL, Shi L, Gong CJ, He ZJ, Wu HJ, Ling TY (2013) Genome-wide analysis of DNA methylation in tongue squamous cell carcinoma. Oncol Rep 29(5):1819–1826. doi:10.​3892/​or.​2013.​2309 PubMed
21.
go back to reference Huang TH, Perry MR, Laux DE (1999) Methylation profiling of CpG islands in human breast cancer cells. Hum Mol Genet 8(3):459–470CrossRefPubMed Huang TH, Perry MR, Laux DE (1999) Methylation profiling of CpG islands in human breast cancer cells. Hum Mol Genet 8(3):459–470CrossRefPubMed
22.
go back to reference Kabekkodu SP, Bhat S, Radhakrishnan R, Aithal A, Mascarenhas R, Pandey D, Rai L, Kushtagi P, Mundyat GP, Satyamoorthy K (2014) DNA promoter methylation-dependent transcription of the double C2-like domain beta (DOC2B) gene regulates tumor growth in human cervical cancer. J Biol Chem 289(15):10637–10649. doi:10.1074/jbc.M113.491506 CrossRefPubMedPubMedCentral Kabekkodu SP, Bhat S, Radhakrishnan R, Aithal A, Mascarenhas R, Pandey D, Rai L, Kushtagi P, Mundyat GP, Satyamoorthy K (2014) DNA promoter methylation-dependent transcription of the double C2-like domain beta (DOC2B) gene regulates tumor growth in human cervical cancer. J Biol Chem 289(15):10637–10649. doi:10.​1074/​jbc.​M113.​491506 CrossRefPubMedPubMedCentral
23.
go back to reference Rotti H, Mallya S, Kabekkodu SP, Chakrabarty S, Bhale S, Bharadwaj R, Bhat BK, Dedge AP, Dhumal VR, Gangadharan GG, Gopinath PM, Govindaraj P, Joshi KS, Kondaiah P, Nair S, Nair SN, Nayak J, Prasanna BV, Shintre P, Sule M, Thangaraj K, Patwardhan B, Valiathan MV, Satyamoorthy K (2015) DNA methylation analysis of phenotype specific stratified Indian population. J Transl Med 13:151. doi:10.1186/s12967-015-0506-0 CrossRefPubMedPubMedCentral Rotti H, Mallya S, Kabekkodu SP, Chakrabarty S, Bhale S, Bharadwaj R, Bhat BK, Dedge AP, Dhumal VR, Gangadharan GG, Gopinath PM, Govindaraj P, Joshi KS, Kondaiah P, Nair S, Nair SN, Nayak J, Prasanna BV, Shintre P, Sule M, Thangaraj K, Patwardhan B, Valiathan MV, Satyamoorthy K (2015) DNA methylation analysis of phenotype specific stratified Indian population. J Transl Med 13:151. doi:10.​1186/​s12967-015-0506-0 CrossRefPubMedPubMedCentral
24.
25.
go back to reference Kabekkodu SP, Bhat S, Pandey D, Varghese VK, Shukla V, Ghosh S, Kushtagi P, Bhat P, Gopinath PM, Satyamoorthy K (2015) Prevalence of human papillomavirus types and phylogenetic analysis of HPV-16 L1 variants from southern India. Asian Pacific journal of cancer prevention : APJCP 16(5):2073–2080CrossRefPubMed Kabekkodu SP, Bhat S, Pandey D, Varghese VK, Shukla V, Ghosh S, Kushtagi P, Bhat P, Gopinath PM, Satyamoorthy K (2015) Prevalence of human papillomavirus types and phylogenetic analysis of HPV-16 L1 variants from southern India. Asian Pacific journal of cancer prevention : APJCP 16(5):2073–2080CrossRefPubMed
26.
go back to reference Calmon MF, Colombo J, Carvalho F, Souza FP, Filho JF, Fukuyama EE, Camargo AA, Caballero OL, Tajara EH, Cordeiro JA, Rahal P (2007) Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM23 in head and neck cancer. Cancer Genet Cytogenet 173(1):31–37. doi:10.1016/j.cancergencyto.2006.09.008 CrossRefPubMed Calmon MF, Colombo J, Carvalho F, Souza FP, Filho JF, Fukuyama EE, Camargo AA, Caballero OL, Tajara EH, Cordeiro JA, Rahal P (2007) Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM23 in head and neck cancer. Cancer Genet Cytogenet 173(1):31–37. doi:10.​1016/​j.​cancergencyto.​2006.​09.​008 CrossRefPubMed
27.
go back to reference Missaoui N, Hmissa S, Trabelsi A, Traore C, Mokni M, Dante R, Frappart L (2011) Promoter hypermethylation of CDH13, DAPK1 and TWIST1 genes in precancerous and cancerous lesions of the uterine cervix. Pathol Res Pract 207(1):37–42. doi:10.1016/j.prp.2010.11.001 CrossRefPubMed Missaoui N, Hmissa S, Trabelsi A, Traore C, Mokni M, Dante R, Frappart L (2011) Promoter hypermethylation of CDH13, DAPK1 and TWIST1 genes in precancerous and cancerous lesions of the uterine cervix. Pathol Res Pract 207(1):37–42. doi:10.​1016/​j.​prp.​2010.​11.​001 CrossRefPubMed
29.
go back to reference Sato N, Koinuma J, Ito T, Tsuchiya E, Kondo S, Nakamura Y, Daigo Y (2010) Activation of an oncogenic TBC1D7 (TBC1 domain family, member 7) protein in pulmonary carcinogenesis. Genes Chromosomes Cancer 49(4):353–367. doi:10.1002/gcc.20747 PubMed Sato N, Koinuma J, Ito T, Tsuchiya E, Kondo S, Nakamura Y, Daigo Y (2010) Activation of an oncogenic TBC1D7 (TBC1 domain family, member 7) protein in pulmonary carcinogenesis. Genes Chromosomes Cancer 49(4):353–367. doi:10.​1002/​gcc.​20747 PubMed
30.
go back to reference Takahashi F, Chiba N, Tajima K, Hayashida T, Shimada T, Takahashi M, Moriyama H, Brachtel E, Edelman EJ, Ramaswamy S, Maheswaran S (2011) Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinib. Oncogene 30(27):3084–3095. doi:10.1038/onc.2011.24 CrossRefPubMed Takahashi F, Chiba N, Tajima K, Hayashida T, Shimada T, Takahashi M, Moriyama H, Brachtel E, Edelman EJ, Ramaswamy S, Maheswaran S (2011) Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinib. Oncogene 30(27):3084–3095. doi:10.​1038/​onc.​2011.​24 CrossRefPubMed
31.
32.
go back to reference Toffolatti L, Scquizzato E, Cavallin S, Canal F, Scarpa M, Stefani PM, Gherlinzoni F, Dei Tos AP (2014) MGMT promoter methylation and correlation with protein expression in primary central nervous system lymphoma. Virchows Arch 465(5):579–586. doi:10.1007/s00428-014-1622-6 CrossRefPubMed Toffolatti L, Scquizzato E, Cavallin S, Canal F, Scarpa M, Stefani PM, Gherlinzoni F, Dei Tos AP (2014) MGMT promoter methylation and correlation with protein expression in primary central nervous system lymphoma. Virchows Arch 465(5):579–586. doi:10.​1007/​s00428-014-1622-6 CrossRefPubMed
33.
go back to reference Rhee YY, Lee TH, Song YS, Wen X, Kim H, Jheon S, Lee CT, Kim J, Cho NY, Chung JH, Kang GH (2015) Prognostic significance of promoter CpG island hypermethylation and repetitive DNA hypomethylation in stage I lung adenocarcinoma. Virchows Arch 466(6):675–683. doi:10.1007/s00428-015-1749-0 CrossRefPubMed Rhee YY, Lee TH, Song YS, Wen X, Kim H, Jheon S, Lee CT, Kim J, Cho NY, Chung JH, Kang GH (2015) Prognostic significance of promoter CpG island hypermethylation and repetitive DNA hypomethylation in stage I lung adenocarcinoma. Virchows Arch 466(6):675–683. doi:10.​1007/​s00428-015-1749-0 CrossRefPubMed
34.
go back to reference Martinez-Glez V, Franco-Hernandez C, Gonzalez-Gomez P, Isla A, De Campos JM, Vaquero J, Gutierrez M, Casartelli C, Rey JA (2007) DAPK1 promoter hypermethylation in brain metastases and peripheral blood. Neoplasma 54(2):123–126PubMed Martinez-Glez V, Franco-Hernandez C, Gonzalez-Gomez P, Isla A, De Campos JM, Vaquero J, Gutierrez M, Casartelli C, Rey JA (2007) DAPK1 promoter hypermethylation in brain metastases and peripheral blood. Neoplasma 54(2):123–126PubMed
37.
go back to reference Mitchell SM, Ross JP, Drew HR, Ho T, Brown GS, Saunders NF, Duesing KR, Buckley MJ, Dunne R, Beetson I, Rand KN, McEvoy A, Thomas ML, Baker RT, Wattchow DA, Young GP, Lockett TJ, Pedersen SK, Lapointe LC, Molloy PL (2014) A panel of genes methylated with high frequency in colorectal cancer. BMC Cancer 14:54. doi:10.1186/1471-2407-14-54 CrossRefPubMedPubMedCentral Mitchell SM, Ross JP, Drew HR, Ho T, Brown GS, Saunders NF, Duesing KR, Buckley MJ, Dunne R, Beetson I, Rand KN, McEvoy A, Thomas ML, Baker RT, Wattchow DA, Young GP, Lockett TJ, Pedersen SK, Lapointe LC, Molloy PL (2014) A panel of genes methylated with high frequency in colorectal cancer. BMC Cancer 14:54. doi:10.​1186/​1471-2407-14-54 CrossRefPubMedPubMedCentral
38.
go back to reference Xu F, Morin C, Mitchell G, Ackerley C, Robinson BH (2004) The role of the LRPPRC (leucine-rich pentatricopeptide repeat cassette) gene in cytochrome oxidase assembly: mutation causes lowered levels of COX (cytochrome C oxidase) I and COX III mRNA. Biochem J 382(Pt 1):331–336. doi:10.1042/BJ20040469 CrossRefPubMedPubMedCentral Xu F, Morin C, Mitchell G, Ackerley C, Robinson BH (2004) The role of the LRPPRC (leucine-rich pentatricopeptide repeat cassette) gene in cytochrome oxidase assembly: mutation causes lowered levels of COX (cytochrome C oxidase) I and COX III mRNA. Biochem J 382(Pt 1):331–336. doi:10.​1042/​BJ20040469 CrossRefPubMedPubMedCentral
39.
41.
go back to reference Tsuchiya N, Fukuda H, Nakashima K, Nagao M, Sugimura T, Nakagama H (2004) LRP130, a single-stranded DNA/RNA-binding protein, localizes at the outer nuclear and endoplasmic reticulum membrane, and interacts with mRNA in vivo. Biochem Biophys Res Commun 317(3):736–743. doi:10.1016/j.bbrc.2004.03.103 CrossRefPubMed Tsuchiya N, Fukuda H, Nakashima K, Nagao M, Sugimura T, Nakagama H (2004) LRP130, a single-stranded DNA/RNA-binding protein, localizes at the outer nuclear and endoplasmic reticulum membrane, and interacts with mRNA in vivo. Biochem Biophys Res Commun 317(3):736–743. doi:10.​1016/​j.​bbrc.​2004.​03.​103 CrossRefPubMed
42.
44.
go back to reference Shan J, Yuan L, Budman DR, Xu HP (2002) WTH3, a new member of the Rab6 gene family, and multidrug resistance. Biochim Biophys Acta 1589(2):112–123CrossRefPubMed Shan J, Yuan L, Budman DR, Xu HP (2002) WTH3, a new member of the Rab6 gene family, and multidrug resistance. Biochim Biophys Acta 1589(2):112–123CrossRefPubMed
48.
go back to reference Morbini P, Benazzo M (2016) Human papillomavirus and head and neck carcinomas: focus on evidence in the babel of published data. Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 36(4):249–258. doi:10.14639/0392-100X-853 Morbini P, Benazzo M (2016) Human papillomavirus and head and neck carcinomas: focus on evidence in the babel of published data. Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 36(4):249–258. doi:10.​14639/​0392-100X-853
Metadata
Title
Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue
Authors
Samatha Bhat
Shama Prasada Kabekkodu
Chinchu Jayaprakash
Raghu Radhakrishnan
Satadru Ray
Kapaettu Satyamoorthy
Publication date
01-04-2017
Publisher
Springer Berlin Heidelberg
Published in
Virchows Archiv / Issue 4/2017
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-017-2094-2

Other articles of this Issue 4/2017

Virchows Archiv 4/2017 Go to the issue